MathewKGeorgeMD

Ophthalmology • Orange City, FL

Anterior Segment Related, Cataract Related, Glaucoma Related

Glaucoma & Cataract specialist

Join to view full profile

Dr. George is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. George's full profile

Already have an account?

Office
2850 Wellness Ave
Orange City, FL 32763
Phone+1 386-574-0700

Fax+1 386-574-1139

Education & Training

Tulane UniversityFellowship, Glaucoma, 2012 - 2013
University of Miami/Bascom Palmer Eye InstituteFellowship, Ocular Immunology/Uveitis, 2011 - 2012
Yale-New Haven Medical CenterResidency, Ophthalmology, 2008 - 2011
Hospital of St RaphaelResidency, Internship, 2007 - 2008
M.S. Ramaiah Medical CollegeClass of 1999, MBBS

Certifications & Licensure

TX State Medical License 2023 - 2026
FL State Medical License 2011 - 2025
PA State Medical License 2023 - 2024
LA State Medical License 2012 - 2014
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Marvin Sears Award for Excellence in Ophthalmology Yale Department of Ophthalmology
Resident Research Award Yale Department of Ophthalmology

Publications & Presentations

PubMed

30 citations
Bilateral irreversible severe vision loss from cosmetic iris implants.
Mathew K George, James C. Tsai, Nils A. Loewen
American Journal of Ophthalmology. 2011-05-01
23 citations
Evaluation of a modified protocol for selective laser trabeculoplasty.
Mathew K George, John W. Emerson, Sameer A. Cheema, Robert McGlynn, Bryce Ford
Journal of Glaucoma. 2008-04-01
6 citations
Coats-like response in linear en coup de sabre scleroderma.
Mathew K George, Carlo Robert Bernardino, John J Huang
Retinal Cases & Brief Reports. 2011-01-01

Journal Articles

Response to aflibercept after frequent re-treatment with bevacizumab or ranibizumab in eyes with neovascular AMD
Thorell MR, Nunes RP, Chen GW, Doshi RR, Dugar J, George MK, Kim BT, Lowrance MD, Modi D, Nahas Z, Gregori G, Yehoshua Z, Feuer W, Rosenfeld PJ, Ophthalmic Surg Lasers Imaging Retina, 11/2014

Professional Memberships

American Academy of Ophthalmology
Fellow

Other Languages

Hindi, Tamil, Spanish, Urdu